FDBusiness.com

Nestle Health Science Develops Brain Health Portfolio With New Acquisition

 Breaking News
  • HKScan Opens New €80 Million Poultry Plant HKScan, the Nordic meat group, has just opened its new, state-of-the-art poultry unit at Rauma in Finland. Valued at over €80 million, the new facility is the largest investment in HKScan’s history. Indeed, the state-of-the-art Rauma unit ranks among the most significant investments in the history of the Finnish food industry. Jari Latvanen, president and chief [...]...
  • Record Growth For UK Food and Drink Exports in First Half of 2017 The first half of 2017 saw exports of all UK food and drink grow to £10.2 billion, up 8.5% on the first half of 2016. This represents the highest first half exports value on record. The UK’s top 3 export products are whisky, salmon and beer. Contrary to recent export trends, stronger growth was reported [...]...
  • Nurturing Locally, Growing Globally – International Meat Congress ICoMST 2017 in Cork The 63rd International Congress of Meat Science and Technology (ICoMST 2017) took place at the Rochestown Park Hotel, Cork, during August 13-18, 2017 and was chaired by Teagasc’s Assistant Director of Research Declan Troy. Over 450 papers were presented at the congress, many by Teagasc researchers. The role of meat in strategies to achieve a sustainable diet [...]...
  • Tempting Batters Now With Clean-label Benefits A leading German natural starch producer, KRÖNER-STÄRKE, perhaps better known as a natural, starch supplier for bread manufacturers, has turned its attention to the convenience market. With a view to cleaning-up the unhealthy image of breaded or battered foodstuffs, the company has succeeded in developing specialist wheat starches which allow food processors to formulate on-trend, [...]...
  • B&R is Introducing a Hypervisor For Its Automation System B&R is introducing a hypervisor for its automation system. This software allows Windows or Linux to run alongside B&R’s own real-time operating system. That enables you to combine the control and HMI applications on a single PC, for example, or have an industrial PC double as both a real-time controller and an edge controller that [...]...
  • Florette Further Expands its UK Business In line with its strategy to be a major player within the UK fresh produce category, Florette UK & Ireland (part of the French Agrial group) has acquired the Wigan site of MyFresh Prepared Produce, a producer of a wide range of salad and vegetable products. MyFresh, Wigan, which employs almost 300 people and was [...]...

Nestle Health Science Develops Brain Health Portfolio With New Acquisition

Nestle Health Science Develops Brain Health Portfolio With New Acquisition
July 20
11:23 2012

Nestle Health Science has acquired a stake in a US firm Accera, to support the ongoing trials and rollout of the firm’s key brand, Axona, a medical food intended for the clinical dietary management of mild to moderate Alzheimer’s disease, already on the market in the US. Axona fits the company’s ambition to develop a strong portfolio of nutrition-based solutions to manage and prevent disease.

Accera is a privately-held US-based company which specialises in the research, development and commercialisation of medical foods for neurodegenerative disorders like Alzheimer’s which affects more than 30 million people worldwide. The terms of the transaction are not being disclosed.

“Our stake in Accera is a strategic step forward in building up our brain health portfolio,” says Nestle Health Science president and chief executive Luis Cantarell. “Axona is an innovative medical food with a well understood mode of action and offers the potential for personalised nutrition for AD patients.”

Alzheimer’s disease (AD) is the most common adult form of dementia and results in chronic and irreversible cognitive impairment. As AD progresses, the brain becomes less able to use glucose for the energy it needs.

Accera’s ongoing clinical trials show that Axona is metabolised by the liver to produce ketone bodies, which are naturally occurring compounds the brain can use as an alternative energy source. This results in improved memory and cognitive function in mild to moderate AD patients. Axona is already on the market in the US, prescribed to up to 30,000 people with mild to moderate Alzheimer’s.

Nestle has many years of experience researching the relationship between nutrition and cognitive function.

Nestle Health Science, a fully owned subsidiary of Nestle, aims to pioneer a new industry between the traditional nutrition and pharmaceutical industries through the development of science-based personalised nutritional solutions and shaping a new approach to disease prevention and management.

Building on its core HealthCare Nutrition business, Nestle Health Science has ambitions to address chronic conditions in the area of Gastrointestinal Health, Metabolic Health and Brain Health.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 11, 2017drinktec
  • September 13, 2017FI Asia
  • September 19, 2017PROCESS EXPO 2017
  • September 22, 2017Global Summit on Food & Beverages
AEC v1.0.4

The Magazine

F&D Business Preferred Suppliers

Advertisements